T1	Outcomes 535 566	central noradrenergic activity,
T2	Outcomes 597 631	DOPEG and MOPEG (measured by HPLC)
T3	Outcomes 643 699	depression, sex, age and diagnostic categories (DSM-III)
T4	Outcomes 1095 1157	positive correlation between plasma levels of DOPEG and MOPEG.
T5	Outcomes 1262 1292	central noradrenergic activity